Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer's brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants (Q44136435)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2002

Language	Label	Description	Also known as
English	Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer's brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants	scientific article published in September 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer's brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Alzheimer's disease

0 references

author name string

John R Fawcett

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Elizabeth Z Bordayo

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Kathy Jackson

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Howard Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jennifer Peterson

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Aleta Svitak

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

William H Frey

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

950

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

10-20

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Generation of hydrogen peroxide by incidental metal ion-catalyzed autooxidation of glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Guanine nucleotide-induced positive cooperativity in muscarinic-cholinergic antagonist binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Technetium-99m labelled imidodiphosphate: an improved bone-scanning radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Intake of flavonoids and risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Inhibitor of antagonist binding to the muscarinic receptor is elevated in Alzheimer's brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to the muscarinic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Use of cholinesterase inhibitors for treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Subcellular localization of bilirubin in rat brain after in vivo i.v. administration of [3H]bilirubin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by the peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Regulation of APP processing. Potential for the therapeutical reduction of brain amyloid burden

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Oxidative damage is the earliest event in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease.

2 references

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bilirubin toxicity and differentiation of cultured astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Oxidative stress, antioxidants, and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Effect of nonsteroidal anti-inflammatory drugs on lipid peroxidation by hydroxyl radical

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902981-5

7 January 2021

Identifiers

10.1016/S0006-8993(02)02981-5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44136435&oldid=2106986320"